The herpes simplex virus latency-associated transcript (LAT) gene is the only viral gene that shows substantial transcriptional activity during neuronal latency. The LAT RNA produced is antisense to the mRNA of the immediate early gene ICP0, partially overlaps the ICP0 mRNA, and is suspected of playing some role in latency. Sequence analysis of the region 5' to the reported transcription start site has not revealed any high consensus RNA polymerase II promoter elements. Nonetheless, LAT RNA is transcribed in low abundance during acute infection in tissue culture. As the initial step in mapping the promoter for this latency-associated gene, we analysed the ability of different regions of the LAT gene to drive the transcription of an indicator gene in vitro.
acute tissue culture infection (Wagner et al., 1988a; Spivack & Fraser, 1988a) , and is not blocked by cycloheximide (Wagner et al., 1988a; Ben-Hur et al., 1989) . However, unlike an alpha gene LAT continues to accumulate until late in infection (Ben-Hur et al., 1989) . This combination of regulatory characteristics distinguishes LAT from alpha, beta and gamma genes. The control region for this gene is therefore of interest not only because of its potential role in latency, but also because it may represent a new class of HSV genes. Although the focus of attention on the LAT gene has been during latency in neurons, LAT is also expressed (but not spliced) early during acute infection in tissue culture (Spivack & Fraser, 1988 a; Wagner et al., 1988 a) . Furthermore, this unspliced transcript has the same apparent size in tissue culture as it has in latently infected neurons (Spivack & Fraser, 1988 a) . Therefore the LAT gene promoter must be capable of functioning not only in neurons during latency but also in tissue culture. It should be possible to localize the tissue culture promoter activity using in vitro mapping procedures.
The LAT gene from nucleotide position -940 to + 2100 (Wechsler et al., 1988 (Wechsler et al., b, 1989 ) was divided into six fragments with appropriate restriction enzymes. Each fragment was then inserted in the proper orientation in front of the gene for chloramphenicol acetyltransferase (CAT) within the plasmid pSVOCAT (Gorman et al., 1982) (Fig. 1 a) . The resulting constructs were transfected into Vero cells by the calcium phosphate precipitation technique (Graham & van der Eb, 1973) . Cell extracts were assayed for CAT activity to assess the ability of the various portions of the LAT gene "to function constitutively as a promoter.
Fragment A (-940 to -662) showed high levels of CAT expression ( Fig. 1 b, lane A), indicating that it had significantly promoter activity in this assay. No fragments between -662 and + 1436, including fragment D which contains a potential TATA box and four Sp 1-binding sites (Wechsler et at., 1989) , exhibited significant CAT activity ( Fig. 1 b, lanes B, C, D and E). Unexpectedly, fragment F (+ 1436 to +2100) showed strong promoter activity comparable to that of fragment A (Fig. 1 ). Fragment F begins over 1400 nucleotides downstream from the 5' end of the LATs and is therefore unlikely to function as a promoter for these transcripts. The function of this potential promoter is unknown.
To characterize further the promoter activity in fragment A, cotransfections were done with a plasmid expressing the HSV-1 virion component Vmw65 (pGR212). Fragment A (and F) promoter activity was increased three-to fivefold by Vmw65 (Fig. 2) . In contrast, Vmw65 stimulated ICP4 promoter activity 64-fold (Table 1) . This is an agreement with Vmw65 stimulation of alpha gene promoters (approximately 40-to 100-fold) reported by others (Campbell et al., 1984; O'Hare & Hayward, 1985 b; Gelman & Silverstein, 1987) . Thus, although the promoter activity of fragment A was stimulated by Vmw65, the extent of stimulation differed from that expected of an alpha gene promoter. As expected, Vmw65 did not induce significant promoter activity of fragments C (+ 151 to +663), D (+663 to +986) or E (+986 to + 1436) or of the SV40 promoter (pSV2CAT). The slight apparent induction of promoter (strain F) (Post et al., 1980) and after addition of HindIII linkers was cloned into the HindIII site of pSVOCAT (Gorman et al., 1982) in front of the coding region of the CAT gene. The orientation of each fragment relative to CAT was confirmed by restriction digestions. The 5' and 3' ends of the 2 kb and 1.3 to 1-5 kb LATs are at nucleotide positions + 1 and + 2140 ( _+ 50), respectively (Wechsler et al., 1988 (Wechsler et al., a, b, 1989 Wagner et al., 1988 b) . Some of the potential promoter-related sequences in fragment A are shown above the fragment. TAATGARAT refers to two partially overlapping sequences that each have partial homology to the consensus Vmw65 binding site TAATGARAT (R is a purine) (Kristie & Roizman, 1984; Mackem & Roizman, 1982) . The sequences are AAATTACAT (nucleotides -748 to -740) and AAATAAAAT ( -753 to -745) . (b) Vero cells (1 x 106) were individually transfected with 5 ~tg of each of the CAT constructs (A to F) by the calcium phosphate precipitation method (Graham & van der Eb, 1973) . After 46 h the cells were harvested, cell extracts were prepared, and CAT assays were performed (Gorman et al., 1982) . Acetylated forms of[ ~ 4C]chloramphenicol were detected by thin-layer chromatography and subsequent autoradiography. Plasmid pSV2CAT (Gorman et al., 1982) , which contains the CAT gene driven by the complete SV40 promoter, was included as a positive control for transfection. C M, [14C]chloramphenico 1 (substrate); Ac-CM, acetylated forms of [14C]chloramphenicol (product). The percentage conversion of chloramphenicol to its acetylated products was determined in three separate experiments. The average and standard error are shown. For each experiment the numbers were corrected for the amount of protein present in the extracts. A plasmid expressing /~-galactosidase (pGA307) was included in each experiment as an internal control for the transfection efficiency. The letter a denotes a statistically significant increase of activity in the presence of Vmw65 (P < 0-002), b denotes no statistically significant increase in activity by Vmw65 (P > 0-19). * Vero cells were cotransfected with 2.5 gg of the indicated promoter-CAT plasmid and 10 gg of either plasmid pXhoI-C (expressing ICP4) or plasmid pGR212 (expressing Vmw65) as described in the legends to Fig. 2 and 3 . t Fragment A is described in the legend to Fig. 1 . The ICP4 promoter is contained in p175KCAT (O'Hare & Hayward, 1984) , TK in pTKCAT (O'Hare & Hayward, 1984) .
~: Stimulation is shown as the fold increase in CAT activity of the promoter-CAT plasmid cotransfected with the indicated gene, compared to the CAT activity of the transfected promoter-CAT plasmid alone.
§ ND, Not done. activity of fragment B ( -6 6 2 to + 151) was not statistically significant and was within negative control levels. The responsiveness of fragment A to stimulation by ICP4 and ICP0 was also tested (Fig. 3 ). Fragment A promoter activity increased up to 10-fold with increasing amounts of ICP4, but increased to at most twofold with ICP0. The slight increase caused by ICP0 was within experimental variation and may not be significant. Fragment F did not respond to either ICP4 or ICP0. HSV-1 beta and gamma gene promoters require expression of ICP4 or other immediate early genes for their induction (Quinlan & Knipe, 1985; O'Hare & Hayward, 1985a; Gelman & Silverstein, 1985 , 1986 Godowski & Knipe, 1986) . Although fragment A was stimulated by ICP4, the level of stimulation was less than that usually seen with beta genes such as thymidine kinase (TK) ( Table 1) (O'Hare & Hayward, 1985a, b) .
In summary, fragment A ( -9 4 0 to -662) was capable of promoter activity in an in vitro CAT assay system, whereas fragments B, C, D and E ( -6 6 2 to + 1436) were not. The basal level of CAT expression by fragment A in the absence of other HSV-1 gene products was consistent with expression of the LAT gene at early times during acute infection in tissue culture. Thus, fragment A may contain the promoter responsible for expression of LAT during acute tissue culture infection.
The regulation of the LAT gene in acutely and latently infected animals and in acutely infected tissue culture cells suggests that this gene is neither an alpha, a beta nor a gamma gene (Spivack & Fraser, 1988a) . Likewise the promoter is neither an alpha, a beta nor a gamma gene promoter. Fragment A's promoter activity following cotransfection with Vmw65 differed from that of an alpha gene. Furthermore, unlike beta and gamma gene promoters, fragment A promoter activity was constitutive and did not require cotransfection with an alpha gene. Thus, the characteristics of the promoter activity in fragment A are not inconsistent with the unique characteristics of the LAT gene promoter.
Promoters are usually located near the 5' start of RNA transcription (position + 1) approximately between nucleotides -1 5 0 and +1 (Corden et al., 1980; McKnight & Kingsbury, 1982) . However, in the above experiments, this region of the LAT gene (fragment B, -6 6 2 to + 151) did not exhibit significant CAT activity in vitro. Although this lack of promoter (Wechsler et al., 1988 b, 1989) . Fragment A is thus a likely candidate for a promoter capable of functioning in tissue culture.
The unusual distance of the potential LAT promoter in fragment A from the 5' end of the LAT RNAs may reflect a unique feature of the transcriptional control of this gene. Alternatively, it is possible that as we previously speculated given the very small amounts of in situ hybridization in this region (Wechsler et al., 1988b) , there may be a 5' exon near the potential promoter in fragment A. Either a small size or rapid degradation could explain why this exon has not been conclusively detected (Wagner et al., 1988b; Wechsler et al., 1988b) .
The results reported above relate to the ability of certain LAT gene sequences to function as a promoter in tissue culture and suggest that fragment A contains the LAT gene promoter responsible for the transcription of the gene early during acute tissue culture infection. Whether the fragment A region is capable of promoter activity during neuronal latency, and whether it is, in fact, also the promoter responsible for transcription during latency, is not known. However, in preliminary experiments (data not shown) fragment A had promoter activity in a mouse neuroblastoma cell line (NB41A3, American Type Culture Collection CCL 147), suggesting that like the LAT gene promoter fragment A may be capable of functioning as a promoter in neurons.
DNA protection studies are in progress to define potential regulatory sequences in or near fragment A that are bound by specific neural and non-neural transcription factors.
